Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Q3 2023 Earnings Call Transcript November 1, 2023
Cerevel Therapeutics Holdings, Inc. beats earnings expectations. Reported EPS is $-0.61, expectations were $-0.63.
Operator: Good morning and welcome to the Cerevel Therapeutics Third Quarter Financial Results Conference call. At this time, all participants are in listen-only mode. Later, you will have the opportunity to ask questions during the Q&A portion of the call. Please note that this...
